Patents by Inventor Shigetoshi Tsubotani

Shigetoshi Tsubotani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060039974
    Abstract: The sustained-release preparation of the present invention, which contains a dipeptidyl peptidase IV inhibitor and a hydrophilic polymer, can appropriately inhibit the DPP-IV activity, and is superior in convenience or compliance.
    Type: Application
    Filed: September 10, 2003
    Publication date: February 23, 2006
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Yohko Akiyama, Yukihiro Matsumoto, Satoru Oi, Nobuhiro Suzuki, Shigetoshi Tsubotani
  • Patent number: 6423869
    Abstract: A compound of the formula (I): wherein R1 represents an amino group which may be substituted; R2 represents a carboxy group which may be esterified or amidated; R3, R4, R5 and R6 each represent a hydroxy group which may be protected; Q represents an aryl group which may be substituted; or a salt thereof is disclosed. The compound (I) possesses ant-Helicobacter pylori activity, and is useful in the prevention or treatment of various diseases associated with Helicobacter bacteria, such as duodenal ulcer, gastric ulcer, chronic gastritis and cancer of the stomach.
    Type: Grant
    Filed: November 1, 1999
    Date of Patent: July 23, 2002
    Assignee: Takeda Chemical Industries, Inc.
    Inventors: Ken-ichiro Miyagawa, Shigetoshi Tsubotani, Masafumi Nakao, Yoshitaka Nakano, Keiji Kamiyama, Motoo Izawa, Yohko Akiyama, Yuji Nishikimi
  • Patent number: 5679708
    Abstract: The present invention relates to a compound of the formula: ##STR1## wherein R.sub.1 stands for an optionally esterified or amidated carboxyl group, X stands for an optionally substituted divalent hydrocarbon residue, R.sub.2 stands for hydrogen or an optionally substituted hydrocarbon residue, R.sub.3 stands for an alkyl group which is substituted with a group bonded through O or S(O).sub.n wherein n is 0, 1 or 2, with a proviso that when the partial structural formula: --NH--X--CO-- is leucine residue, R.sub.3 is not 3-hydroxy-3-methylbutyl group nor 4-hydroxy-3-methylbutyl group, or a salt thereof, which is useful as prophylactic and therapeutic agents of bone diseases and as inhibitory agents of thiol protease.
    Type: Grant
    Filed: September 5, 1995
    Date of Patent: October 21, 1997
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Shigetoshi Tsubotani, Masayuki Takizawa, Junji Mizoguchi
  • Patent number: 5668128
    Abstract: The present invention relates to a compound of the formula: ##STR1## wherein R.sub.1 and Q are independently an optionally esterified or amidated carboxyl group; R.sub.2 is hydrogen, an acyl group or an optionally substituted hydrocarbon residue; X is a divalent hydrocarbon residue which may be substituted; or a salt thereof, which is useful as prophylactic and therapeutic agents of bone diseases and as agents for inhibiting thiol protease.
    Type: Grant
    Filed: September 5, 1995
    Date of Patent: September 16, 1997
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Shigetoshi Tsubotani, Masayuki Takizawa, Mikio Shirasaki, Junji Mizoguchi, Yoshiaki Shimizu
  • Patent number: 5556853
    Abstract: A compound of the general formula: ##STR1## wherein R.sup.1 represents a carboxyl group which may optionally be esterified or amidated; R.sup.2 represents a cyclic group which may optionally be substituted or a polar group; n is an integer of 0 to 6; R.sup.3 represents hydrogen or a hydrocarbon residue which may optionally be substituted; R.sup.4 represents (1) a hydrocarbon residue which is substituted by an optionally protected amino group or (2) an alkenyl group; or R.sup.3 and R.sup.4 may be combined with the adjacent nitrogen atom to form a heterocyclic group containing at least two hetero atoms, or a salt thereof.The compound or a salt thereof of the present invention inhibits thiol proteases such as cathepsin L and B and serves well as a prophylactic/therapeutic agent for bone diseases such as osteoporosis.
    Type: Grant
    Filed: October 27, 1994
    Date of Patent: September 17, 1996
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Shigetoshi Tsubotani, Takizawa Masayuki, Shirasaki Mikio, Yukio Fujisawa
  • Patent number: 5310741
    Abstract: A compound of the formula ##STR1## wherein R.sup.1 is hydrogen or a hydrocarbon residue which may be substituted; R.sup.2 is oxo or hydrogen plus hydroxy which may be acylated; R.sup.3 is hydrogen or hydroxy which may be acylated; at least one of the dotted lines represents a single bond, or a salt thereof, produced from Penicillum thomii has potent RA-89 muscarinic receptor blocking activity and is of value as therapeutic agent for parkinsonism, ulcer, etc. or as mydriatics.
    Type: Grant
    Filed: April 22, 1991
    Date of Patent: May 10, 1994
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hideo Shirafuji, Shigetoshi Tsubotani, Takenori Ishimaru, Setsuo Harada
  • Patent number: 4895864
    Abstract: As the novel antibiotic TAN-950A having the structural formula ##STR1## and salt thereof of the present invention show antimicrobial action against fungi, they can be used in the therapeutics of fungal infections, in human and other animals etc. by oral, parenteral or external administration.
    Type: Grant
    Filed: April 22, 1988
    Date of Patent: January 23, 1990
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Takashi Iwasa, Shigetoshi Tsubotani, Setsuo Harada
  • Patent number: 4723004
    Abstract: A compound of the formula: ##STR1## wherein R.sup.1 is ##STR2## HOOC--(CH.sub.2).sub.3 --CO-- or hydrogen, or a salt thereof, is useful as an intermediate for the production of cephem compounds, and some of them are useful as antimicrobial agents.
    Type: Grant
    Filed: December 14, 1984
    Date of Patent: February 2, 1988
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Setsuo Harada, Shigetoshi Tsubotani, Hideo Ono
  • Patent number: 4497742
    Abstract: Compounds of the formula (I): ##STR1## wherein R is an ethyl group which may optionally be substituted and n is 0 or 1, or a physiologically acceptable salt thereof, can be produced by subjecting to isomerization a compound of the formula (II): ##STR2## wherein R and n have the same meaning as defined above, or a salt thereof, by using a quaternary ammonium halide and are useful as a bactericide or disinfectant, and also a synergistic effect with penicillin and/or cephalosporin antibiotic agents.Among the compounds of the formula (I), compounds shown by the formula: ##STR3## wherein R.sub.6 is H or --SO.sub.3 H, as well as salts thereof, are novel.
    Type: Grant
    Filed: February 24, 1982
    Date of Patent: February 5, 1985
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Setsuo Harada, Shigetoshi Tsubotani, Mitsuko Asai